Zealand Pharma A/S Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/22/2022 | Q1 2022 | -$4.15 | $15.08 M | |||
| 11/12/2021 | Q3 2021 | -$4.61 | $106.41 M | |||
| 08/13/2021 | Q4 2021 | -$6.49 | $54.02 M | |||
| 08/13/2021 | Q2 2021 | -$6.87 | $84.33 M | |||
| 03/12/2021 | Q1 2021 | -$5.75 | $47.82 M | |||
| 03/18/2021 | Q4 2020 | -$9.03 | $63.36 M | |||
| 11/13/2020 | Q3 2020 | -$5.76 | $56.53 M | |||
| 06/29/2020 | Q2 2020 | -$1.57 | $221.02 M | |||
| 03/30/2020 | Q1 2020 | -$4.98 | $12.42 M | |||
| 03/13/2020 | Q4 2019 | -$5.37 | $11.49 M | |||
| 09/29/2019 | Q3 2019 | -$3.44 | $9.92 M | |||
| 06/29/2019 | Q2 2019 | -$4.33 | $19.92 M | |||
| 03/30/2019 | Q1 2019 | -$4.13 | $0 | |||
| 03/15/2019 | Q4 2018 | -$3.99 | $13.12 M | |||
| 09/29/2018 | Q3 2018 | $30.10 | $0 | |||
| 06/29/2018 | Q2 2018 | -$4.14 | $15.14 M | |||
| 03/30/2018 | Q1 2018 | -$2.97 | $10.83 M | |||
| 03/13/2018 | Q4 2017 | -$3.58 | $11.28 M | |||
| 09/29/2017 | Q3 2017 | -$1.48 | $40.08 M | |||
| 06/29/2017 | Q2 2017 | -$3.66 | $10.80 M |
Zealand Pharma A/S Earnings: Frequently Asked Questions
-
How can I listen to Zealand Pharma A/S's earnings conference call?
The conference call for Zealand Pharma A/S's latest earnings report can be listened to online.
-
How can I read Zealand Pharma A/S's conference call transcript?
The conference call transcript for Zealand Pharma A/S's latest earnings report can be read online.
-
How much revenue does Zealand Pharma A/S generate each year?
Zealand Pharma A/S (:ZEAL) has a recorded annual revenue of $292.57 M.
-
How much profit does Zealand Pharma A/S generate each year?
Zealand Pharma A/S (:ZEAL) has a recorded net income of $292.57 M. Zealand Pharma A/S has generated $-26.54 earnings per share over the last four quarters.
-
What is Zealand Pharma A/S's price-to-earnings ratio?
Zealand Pharma A/S (:ZEAL) has a price-to-earnings ratio of -4.52 and price/earnings-to-growth ratio is -0.21.
